Influence of Surgical Procedures on Serum Paraoxonase-1-Related Variables and Markers of Inflammation in Hospitalized Patients

References

• Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152(3):292–298. doi:10.1001/jamasurg.2016.4952.
   PubMed Web of Science ®Google Scholar
• Kehlet H, Wilmore DW. Surgical care-how can new evidence be applied to clinical practice? Colorectal Dis.2010;12(1):2–4. doi:10.1111/j.1463-1318.2009.02077.x.
   PubMed Web of Science ®Google Scholar
• Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg. 2008;248(2):189–198. doi:10.1097/SLA.0b013e31817f2c1a.
   PubMed Web of Science ®Google Scholar
• Prete A, Yan Q, Al-Tarrah K, et al. The cortisol stress response induced by surgery: a systematic review and meta-analysis. Clin Endocrinol. 2018;89(5):554–567. doi:10.1111/cen.13820.
   PubMed Web of Science ®Google Scholar
• Tsilimigras DI, Sigala F, Karaolanis G, et al. Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review. Acta Pharmacol Sin. 2018;39(7):1164–1175. doi:10.1038/aps.2017.212.
   PubMed Web of Science ®Google Scholar
• Tsuchiya M, Shiomoto K, Mizutani K, et al. Reduction of oxidative stress a key for enhanced postoperative recovery with fewer complications in esophageal surgery patients: randomized control trial to investigate therapeutic impact of anesthesia management and usefulness of simple blood test for prediction of high-risk patients. Medicine (Baltimore). 2018;97:e12845. doi:10.1097/MD.0000000000012845.
   PubMed Web of Science ®Google Scholar
• Camps J, Rodríguez-Gallego E, García-Heredia A, et al. Paraoxonases and chemokine (C-C motif) ligand-2 in noncommunicable diseases. Adv Clin Chem 2014;63:247–308.
   PubMed Web of Science ®Google Scholar
• Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995;96(6):2882–2891. doi:10.1172/JCI118359.
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest. 1998;101(8):1581–1590. doi:10.1172/JCI1649.
   PubMed Web of Science ®Google Scholar
• Iftimie S, García-Heredia A, Pujol I, et al. Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria. Eur J Clin Microbiol Infect Dis. 2016;35(9):1417–1424. doi:10.1007/s10096-016-2679-8.
   PubMed Web of Science ®Google Scholar
• Iftimie S, García-Heredia A, Pujol I, et al. A preliminary study of paraoxonase-1 in infected patients with an indwelling central venous catheter. Clin Biochem.2016;49(6):449–457. doi:10.1016/j.clinbiochem.2015.11.006.
   PubMed Web of Science ®Google Scholar
• Camps J, Iftimie S, García-Heredia A, Castro A, Joven J. Paraoxonases and infectious diseases. Clin Biochem.2017;50(13/14):804–811. doi:10.1016/j.clinbiochem.2017.04.016.
   PubMed Web of Science ®Google Scholar
• Iftimie S, García-Heredia A, Pujol-Bosch F, et al. Serum paraoxonase-1 concentration as a potential predictor of urinary bladder cancer recurrence. A five year follow-up study. Arch Med Res.2018;49(2):119–122. doi:10.1016/j.arcmed.2018.04.011.
   PubMed Web of Science ®Google Scholar
• McCabe WR, Jackson GG. Gram-negative bacteremia. I. Arch Intern Med. 1962;110(6):847–864. doi:10.1001/archinte.1962.03620240029006.
   Google Scholar
• Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med. 1992;117(12):1003–1009.
   PubMed Web of Science ®Google Scholar
• House of Delegates/Executive Committee. ASA physical status classification system. https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system, 2014 (accessed 11 January 2019).
   Google Scholar
• Aranda N, Viteri FE, Montserrat C, Arija V. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain. Ann Hematol. 2010;89(8):767–773. doi:10.1007/s00277-010-0901-9.
   PubMed Web of Science ®Google Scholar
• Marsillach J, Aragonès G, Beltrán R, et al. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem.2009;42(1-2):91–98. doi:10.1016/j.clinbiochem.2008.09.120.
   PubMed Web of Science ®Google Scholar
• Reddy ST, Wadleigh DJ, Grijalva V, et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol. 2001;21(4):542–547.
   PubMed Web of Science ®Google Scholar
• Uzun H, Zengin K, Taskin M, Aydin S, Simsek G, Dariyerli N. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg. 2004;14(5):659–665. doi:10.1381/096089204323093453.
   PubMed Web of Science ®Google Scholar
• Koksal H, Kurban S. Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy. Clinics (Sao Paulo). 2010;65(3):285–290. doi:10.1590/S1807-59322010000300008.
   PubMed Web of Science ®Google Scholar
• Wysocka A, Cybulski M, Berbeć H, et al. Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery. BMC Cardiovasc Disord 2017;17(1):92. doi:10.1186/s12872-017-0528-z.
   PubMedGoogle Scholar
• Alici HA, Ekinci D, Beydemir S. Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo. Clin Biochem.2008;41(16/17):1384–1390. doi:10.1016/j.clinbiochem.2008.06.017.
   PubMed Web of Science ®Google Scholar
• Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci.2009;46(2):83–106. doi:10.1080/10408360802610878.
   PubMed Web of Science ®Google Scholar
• Csendes A, Burgos AM, Roizblatt D, Garay C, Bezama P. Inflammatory response measured by body temperature, C-reactive protein and white blood cell count 1, 3, and 5 days after laparotomic or laparoscopic gastric bypass surgery. Obes Surg. 2009;19(7):890–893. doi:10.1007/s11695-008-9702-9.
   PubMed Web of Science ®Google Scholar
• Inada R, Yamamoto S, Oshiro T, Takawa M, Fujita S, Akasu T. Case-matched comparison of the short-term outcomes between laparoscopic and open abdominoperineal resection for rectal cancer. Surg Today. 2014;44(4):640–645. doi:10.1007/s00595-013-0611-8.
   PubMed Web of Science ®Google Scholar
• Gumbau V, Bruna M, Canelles E, et al. A prospective study on inflammatory parameters in obese patients after sleeve gastrectomy. Obes Surg. 2014;24(6):903–908. doi:10.1007/s11695-014-1186-1.
   PubMed Web of Science ®Google Scholar
• Villard MA, Helm MC, Kindel TL, Goldblatt MI, Gould JC, Higgins RM. C-reactive protein as a predictor of post-operative complications in bariatric surgery patients. Surg Endosc 2018; Oct 19. [Epub ahead of print]. doi:10.1007/s00464-018-6534-0.
   PubMed Web of Science ®Google Scholar
• Chand M, Armstrong T, Britton G, Nash GF. How and why do we measure surgical risk?. J R Soc Med. 2007;100(11):508–512. doi:10.1177/014107680710001113.
   PubMed Web of Science ®Google Scholar
• Boyd O, Jackson N. How is risk defined in high-risk surgical patient management? Crit Care. 2005;9(4):390–396. doi:10.1186/cc3057.
   PubMed Web of Science ®Google Scholar
• Reilly JS, Coignard B, Price L, et al. The reliability of the McCabe score as a marker of co-morbidity in healthcare-associated infection point prevalence studies. J Infect Prev.2016;17(3):127–129. doi:10.1177/1757177415617245.
   PubMedGoogle Scholar
• Quan H, Li B, Couris CM, Fushimi K, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol.2011;173(6):676–682. doi:10.1093/aje/kwq433.
   PubMed Web of Science ®Google Scholar
• Davenport DL, Bowe EA, Henderson WG, Khuri SF, Mentzer Jr RM. National Surgical Quality Improvement Program (NSQIP) risk factors can be used to validate American Society of Anesthesiologists Physical Status Classification (ASA PS) levels. Ann Surg.2006;243(5):636–641. doi:10.1097/01.sla.0000216508.95556.cc.
   PubMed Web of Science ®Google Scholar